Statistics from Altmetric.com
A 51-year-old woman 8 years post- human leukocyte antigen (HLA)-matched allogeneic haematopoietic cell transplant presented to her gynaecologist with abdominal pain and a new, large abdominopelvic mass that had gradually grown over a few weeks. She reported severe vomiting followed by days of debilitating abdominal pain during a self-limited gastroenteritis 4 weeks earlier. Her medical history was notable for follicular lymphoma with associated splenomegaly. While she achieved complete remission after haematopoietic cell transplant, she continued to have thrombocytopaenia. She had no history of abdominal surgery and had one vaginal birth. At presentation, she complained of mild abdominal pain and fullness in her lower abdomen and denied other systemic or gastrointestinal symptoms. Her physical examination was notable only for a firm, non-tender abdominopelvic mass spanning most of her lower abdomen. Her labs were significant for thrombocytopaenia (132 k/uL) and mildly low white blood cell count (WBC 2.79 K/uL) and a normal haemoglobin and haematocrit (12.3 g/dL/36.9%). A CT scan with intravenous contrast was performed and compared with prior scans. Imaging showed the spleen and an accompanying large subcapsular haematoma forming the large pelvic mass. The subcapsular haematoma disrupted the spleen’s normal ligamentous attachments and had pulled it from its normal location (figure 1) into the pelvis by gravity (figures 2 and 3). During her uncomplicated open splenectomy, it was revealed that all normal attachments to the spleen were absent except for the vascular pedicle at the splenic hilum. She recovered well and by postoperative week 4, her blood counts normalised (WBC 5.47 K/uL, haemoglobin 12.7 g/dL, haematocrit 38.5%, platelets 469 k/uL). Her final pathology revealed a 17×12×5 cm spleen with congestion and without evidence of lymphoma. The only identifiable aetiology for the subcapsular splenic haemorrhage was the episode of severe emesis 2 months prior to presentation in the setting of relative thrombocytopaenia.
A wandering spleen comprises less than 0.2% of all splenectomies and is characterised by migration of the spleen from the left upper quadrant to elsewhere in the abdomen.1 Most patients present in childhood, resulting from a congenital anomaly in the mesogastrium or splenic suspensory ligaments or in adulthood when women develop an acquired laxity of those ligaments after hormonal changes in pregnancy.1 2 The most common presentation is an asymptomatic abdominal mass or abdominal pain caused by torsion of the spleen on its pedicle.2 Several medical conditions present in our case, including a history of splenomegaly, lymphoma and prior pregnancy, are known risk factors for spleen migration.3 Thus, a wandering spleen should be on the differential diagnosis for any new abdominal mass in patients with any of these factors, especially in cases with thrombocytopaenia posing additional risk of subcapsular haemorrhage. Patients who experience torsion of the splenic vascular pedicle or spleen necrosis may present with an acute abdomen1 and CT scans are the preferred diagnostic study.1 Splenectomy has been the treatment of choice but splenopexy has been successfully reported in patients with viable spleens.1 3 Our patient underwent a splenectomy due to the large subcapsular haematoma, after which her thrombocytopaenia resolved.
Splenic subcapsular haematomas, previous pregnancies, splenomegaly and lymphoma are risk factors for a wandering spleen.
CT scan is the preferred diagnostic study and a delay in diagnosis can result in torsion of the splenic vascular pedicle and splenic necrosis, leading to an acute abdomen.
Both splenectomy and splenopexy are surgical options, but splenopexy preserves the immunological function of the spleen.
We would like to thank Dr Andrew Dwyer (deceased) for his astute radiographic diagnosis of this wandering spleen.
Contributors CMK and PS cared for the patient during the acute episode described in the case and prepared the manuscript. DHF was the primary investigator for the patient’s haematopoietic cell transplant that resulted in the acute episode and has reviewed and edited the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.